BERLIN, Germany, June 02, 2022 / B3C newswire / --The Berlin-based biopharmaceutical enterprise ProBioGen has increased its staff by 50 percent since April 2020. More than 250 "ProBioGeniuses", as ...

BERLIN, Germany, January 10, 2023 / B3C newswire / -- ProBioGen announced today a new non-exclusive collaboration with Boehringer Ingelheim on ProBioGen's DirectedLuck® transposase technology.

ATLANTA, GA and BERLIN, Germany, Sept. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against ...

Berlin, Germany & Zurich, Switzerland – April 12, 2023-- ProBioGen and ImmunOs Therapeutics announce the extension of their partnership for further large-scale manufacturing of clinical material for ...

Berlin, Germany and Vancouver, Canada, October 14, 2015 / B3C newswire / --ProBioGen AG, a leading specialist for contract development and manufacturing of complex glycoproteins, and Zymeworks Inc., a ...

Berlin, Germany, and Utrecht, The Netherlands - March 4, 2014 – ProBioGen AG and Merus B.V. today announced that the companies have signed a non-exclusive commercial option and license agreement on ...

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and ProBioGen, a leading CDMO in biologics, vaccines and viral vectors, announce that ...

Contract manufacturer ProBioGen is joining a growing list of companies that are expanding their biologics manufacturing capabilities as more drugmakers need production expertise for cell-based drugs.

Transgene and ProBioGen, a CDMO, inked a license agreement for ProBioGen’s AGE1.CR.pIX ® suspension cell line which will combine ProBioGen’s specific production technology with the manufacturing ...

SCOTTSDALE, Ariz., Nov. 1, 2018 /PRNewswire-PRWeb/ -- Probiogen, part of leading global wellness company, WR Group, announced today that its range of premium probiotics are now available at over 1,600 ...

ProBioGen announced that it has signed an agreement with Emergent BioSolutions for a non-exclusive commercial multi-product license and option agreement under which Emergent will be granted broad ...